Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

BACKGROUND/AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer disease. METHODS: Between 2002 and 2014, 110 patients in 14 medical centers received levofloxacin-based third-...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Gut Liver
Main Authors: Lim, Joo Hyun, Kim, Sang Gyun, Song, Ji Hyun, Hwang, Jae Jin, Lee, Dong Ho, Han, Jae Pil, Hong, Su Jin, Kim, Ji Hyun, Jeon, Seong Woo, Kim, Gwang Ha, Shim, Ki-Nam, Shin, Woon Geon, Kim, Tae Ho, Kim, Sun Moon, Chung, Il-Kwon, Kim, Hyun-Soo, Kim, Heung Up, Lee, Joongyub, Kim, Jae Gyu
פורמט: Artigo
שפה:Inglês
יצא לאור: Editorial Office of Gut and Liver 2017
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347646/
https://ncbi.nlm.nih.gov/pubmed/27609487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16099
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים